|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Phase I study of matuzumab in combination with 5-fluorouracil, leucovorin and cisplatin (PLF) in patients with advanced gastric and esophagogastric adenocarcinomas显示文摘 | Tanja Trarbach Marta Przyborek Norbert Schleucher Steffen Heeger Christian Lüpfert Udo Vanhoefer | 2013 | Investigational New Drugs2013，，3： | 3 |
| 2 | An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer显示文摘 | M. Moehler A. Mueller J.T. Hartmann M.P. Ebert S.E. Al-Batran P. Reimer M. Weihrauch F. Lordick T. Trarbach S. Biesterfeld M. Kabisch D. Wachtlin P.R. Galle | 2011 | European Journal of Cancer2011，，10： | 3 |
| 3 | Mutational analysis of TAC3 and TACR3 genes in patients with idiopathic central pubertal disorders显示文摘 | Tusset C Noel SD Trarbach EB | 2012 | Arq Bras Endocrinol Metabol2012，56，9： | 1 |
| 4 | Genetics basis for GnRH dependent pubertal disorders in humans显示文摘 | Silveira L F Trarbach E B Latronico A C | 2010 | Mol Cell Endocrinol2010，324，： | 1 |
| 5 | Mutational analysis of TAC3 and TACR3 genes in patients with idiopathic central pubertal disorders显示文摘 | Tusset C Noel S D Trarbach E B | 2012 | Arq Bras Endocrinol Metabol2012，56，9： | 1 |
| 6 | Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer:a prospective multi-center biomarker-oriented phase Ⅱ study显示文摘 | Moehler M Mueller A Trarbach T Lordick F Seufferlein T Kubicka S | 2011 | Ann Oncol2011，22，： | 1 |
| 7 | Cetuximab with irinote- can, folinic acid and 5-fluorouracil as first-line treatment in ad- vanced gastroesophageal cancer: a prospective multi-center bin- marker- oriented phase l/study 显示文摘 | Moehler M Mueller T Trarbach T | 2011 | Ann Oncol2011，22，6： | 1 |
| 8 | A multicenter, rarldomized phase Ⅱ trial of gemcitabine and oxaliplatin alone or in combina- tion with biweekly cetuximab in the ftrst line treatment of advanced biliary cancer: An interim analysis of the BINGO trial显示文摘 | Malka D Trarbach T Fartoux L | 2009 | J Clin On- col2009，27，7： | 1 |
| 9 | Cetuximab with irino- tecan, folinic acid and 5-fluorouracil as first-line treatment in ad- vanced gastroesophageal cancer: a prospective multi-center bio- marker-oriented phase II study 显示文摘 | Moehler M Mueller A Trarbach T | 2011 | Ann Oncol2011，22，6： | 1 |
| 10 | A multicenter, randomized phase Ⅱ trial of gemcitabine and oxaliplatin (GEMOX) alone or in combination with biweekly cetuximab in the first-line treatment of advanced biliary cancer : interim analysis of the BINGO trial 显示文摘 | Malka D Trarbach T Fartoux L | 2009 | J Clin Oncol2009，27，15： | 1 |
| 11 | Phase Ⅱ trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer显示文摘 | Trarbach T Moehler M Heinemann V | 2010 | BrJ Cancer2010，102，3： | 1 |
| 12 | Randomized, placebo-con- trolled, phase llI study of first-line oxaliplatin-based chemotherapy plus PTK787/ZK 222584, an oral vascular endothelial growth factor re- ceptor inhibitor, in patients with metastatic coloreetal adenocarcinoma 显示文摘 | Hecht JR Trarbach T Hainsworth JD | 2011 | Journal of Clinical Ontology2011，29，15： | 1 |
| 13 | Clinical assessment and molecular analysis of GnRHR and KAL1 genes in males with idiopathic hypogonadotrophic hypogonadism显示文摘 | Versiani BR Trarbach E Koenigkam-Santos M | 2007 | Clin Endocrinol(Oxf)2007，66，2： | 1 |
| 14 | PhaseⅡtrial of mapatum umab,a fully hum an agonistic mono-clonal antibody that targets and activates the tumour nec-rosis factor apoptosis-inducing ligand receptor-1(TRAII-R1),in patients with refractory colorectal cancer显示文摘 | Trarbach T Moehler M Heinemann V | 2010 | Br JCancer2010，102，3： | 1 |
| 15 | Phase Ⅰ/Ⅱ study of PTK787/ZK222584 (PTK/ZK),a novel,oral angiogenesis inhibitor in combination with folfiri as first-line treatment for patients with metastatic colorectal cancer显示文摘 | Schleucher N Junker U | 2004 | J Clin Oncol2004，23，16： | 1 |
| 16 | Genetic insights into human isolated gonadotropin deficiency显示文摘 | Trarbach EB Silveira LG Latronico AC | 2007 | Pituitary2007，10，4： | 1 |
| 17 | Phase Ⅰ study of the humanized anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in patients (pts) with advanced esophago-gastric (EG) adenocarcinoma (Abstr) 显示文摘 | Trarbach ML Schleucher N Weber D | 2005 | Proe Am Soe Clin Oncol2005，24，： | 1 |
| 18 | Cetuximab with irinotecan/folinic acid/5-FU as first-line treatment in advanced gastric cancer:a nonrandomized multicenter AIO phase Ⅱ study显示文摘 | Kanzler S Trarbach T Seufferlein T | 2009 | J Clin Oncol2009，27，15： | 1 |
| 19 | Role of kisspeptin/GPR54 system in human reproductive axis显示文摘 | Silveira LF Teles MG Trarbach EB | 2010 | Front Horm Res2010，39，： | 1 |
| 20 | Cetuximab with irinotecan , folinic acid and 5-fluorouracil as firstline treatment in advancedgastroesophageal cancer: a prospective multi-center biomarker-oriented phase II study显示文摘 | Moehler M Mueller A Trarbach T | 2011 | Ann Oncol2011，22，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员